Loading...
Validation of [(18)F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor
BACKGROUND: 3′-Deoxy-3′-[(18)F]fluorothymidine ([(18)F]FLT) was proposed as an imaging biomarker for the assessment of in vivo cellular proliferation with positron emission tomography (PET). The current study aimed to validate [(18)F]FLT as a perfusion-independent PET tracer, by gaining insight in t...
Na minha lista:
| Udgivet i: | EJNMMI Res |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5874225/ https://ncbi.nlm.nih.gov/pubmed/29594931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-018-0376-6 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|